"Oligodendroglioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655)
| Descriptor ID |
D009837
|
| MeSH Number(s) |
C04.557.465.625.600.380.590 C04.557.470.670.380.590 C04.557.580.625.600.380.590
|
| Concept/Terms |
Mixed Oligodendroglioma-Astrocytoma- Mixed Oligodendroglioma-Astrocytoma
- Mixed Oligodendroglioma Astrocytoma
- Mixed Oligodendroglioma-Astrocytomas
- Oligodendroglioma-Astrocytoma, Mixed
- Oligodendroglioma-Astrocytomas, Mixed
Mixed Oligodendroglioma-Ependymoma- Mixed Oligodendroglioma-Ependymoma
- Mixed Oligodendroglioma Ependymoma
- Mixed Oligodendroglioma-Ependymomas
- Oligodendroglioma-Ependymoma, Mixed
- Oligodendroglioma-Ependymomas, Mixed
Oligodendroglioma, Adult- Oligodendroglioma, Adult
- Adult Oligodendroglioma
- Adult Oligodendrogliomas
- Oligodendrogliomas, Adult
Oligodendroglioma, Childhood- Oligodendroglioma, Childhood
- Childhood Oligodendroglioma
- Childhood Oligodendrogliomas
- Oligodendrogliomas, Childhood
Oligodendroglioma, Well-Differentiated- Oligodendroglioma, Well-Differentiated
- Oligodendroglioma, Well Differentiated
- Oligodendrogliomas, Well-Differentiated
- Well-Differentiated Oligodendrogliomas
- Well-Differentiated Oligodendroglioma
- Well Differentiated Oligodendroglioma
Anaplastic Oligodendroglioma- Anaplastic Oligodendroglioma
- Anaplastic Oligodendrogliomas
- Oligodendroglioma, Anaplastic
- Oligodendrogliomas, Anaplastic
|
Below are MeSH descriptors whose meaning is more general than "Oligodendroglioma".
Below are MeSH descriptors whose meaning is more specific than "Oligodendroglioma".
This graph shows the total number of publications written about "Oligodendroglioma" by people in this website by year, and whether "Oligodendroglioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 4 | 0 | 4 |
| 2016 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oligodendroglioma" by people in Profiles.
-
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol. 2022 02 01; 40(4):403-426.
-
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.
-
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Neuro Oncol. 2019 09 06; 21(9):1164-1174.
-
Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line. J Lipid Res. 2016 11; 57(11):2028-2039.
-
Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report. Neurosurgery. 2016 Mar; 78(3):E466-73.
-
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol. 2014 Jan; 16(1):123-30.
-
Acetate supplementation induces growth arrest of NG2/PDGFRa-positive oligodendroglioma-derived tumor-initiating cells. PLoS One. 2013; 8(11):e80714.
-
Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas. Neuroradiol J. 2013 Aug; 26(4):385-95.
-
N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. J Biol Chem. 2013 Sep 06; 288(36):26188-26200.
-
Left unilateral electroconvulsive therapy (ECT) after oligodendroglioma resection. J ECT. 2011 Dec; 27(4):273-4.